208 related articles for article (PubMed ID: 26095193)
21. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
Pfaller CK; George CX; Samuel CE
Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
[TBL] [Abstract][Full Text] [Related]
22. To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.
Erdmann EA; Mahapatra A; Mukherjee P; Yang B; Hundley HA
Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):54-87. PubMed ID: 33356612
[TBL] [Abstract][Full Text] [Related]
23. Methods for recruiting endogenous and exogenous ADAR enzymes for site-specific RNA editing.
Xiang Y; Katrekar D; Mali P
Methods; 2022 Sep; 205():158-166. PubMed ID: 35779766
[TBL] [Abstract][Full Text] [Related]
24. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
[TBL] [Abstract][Full Text] [Related]
25. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
[TBL] [Abstract][Full Text] [Related]
26. Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.
Freund EC; Sapiro AL; Li Q; Linder S; Moresco JJ; Yates JR; Li JB
Cell Rep; 2020 May; 31(7):107656. PubMed ID: 32433965
[TBL] [Abstract][Full Text] [Related]
27. ICLAMP: a novel technique to explore adenosine deamination via inosine chemical labeling and affinity molecular purification.
Yang Y; Nakayama K; Okada S; Sato K; Wada T; Sakaguchi Y; Murayama A; Suzuki T; Sakurai M
FEBS Lett; 2024 May; 598(9):1080-1093. PubMed ID: 38523059
[TBL] [Abstract][Full Text] [Related]
28. ADAR1 and ADAR2 expression and editing activity during forebrain development.
Jacobs MM; Fogg RL; Emeson RB; Stanwood GD
Dev Neurosci; 2009; 31(3):223-37. PubMed ID: 19325227
[TBL] [Abstract][Full Text] [Related]
29. Current strategies for Site-Directed RNA Editing using ADARs.
Montiel-Gonzalez MF; Diaz Quiroz JF; Rosenthal JJC
Methods; 2019 Mar; 156():16-24. PubMed ID: 30502398
[TBL] [Abstract][Full Text] [Related]
30. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
Fritzell K; Xu LD; Lagergren J; Öhman M
Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
[TBL] [Abstract][Full Text] [Related]
31. Editing of glutamate receptor subunit B pre-mRNA in vitro by site-specific deamination of adenosine.
Yang JH; Sklar P; Axel R; Maniatis T
Nature; 1995 Mar; 374(6517):77-81. PubMed ID: 7870177
[TBL] [Abstract][Full Text] [Related]
32. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.
Chen CX; Cho DS; Wang Q; Lai F; Carter KC; Nishikura K
RNA; 2000 May; 6(5):755-67. PubMed ID: 10836796
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
Wang C; Zou J; Ma X; Wang E; Peng G
Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
[TBL] [Abstract][Full Text] [Related]
34. Editing independent effects of ADARs on the miRNA/siRNA pathways.
Heale BS; Keegan LP; McGurk L; Michlewski G; Brindle J; Stanton CM; Caceres JF; O'Connell MA
EMBO J; 2009 Oct; 28(20):3145-56. PubMed ID: 19713932
[TBL] [Abstract][Full Text] [Related]
35. A method to find tissue-specific novel sites of selective adenosine deamination.
Ohlson J; Ensterö M; Sjöberg BM; Ohman M
Nucleic Acids Res; 2005 Oct; 33(19):e167. PubMed ID: 16257978
[TBL] [Abstract][Full Text] [Related]
36. Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs.
Walkley CR; Li JB
Genome Biol; 2017 Oct; 18(1):205. PubMed ID: 29084589
[TBL] [Abstract][Full Text] [Related]
37. To edit or not to edit: regulation of ADAR editing specificity and efficiency.
Deffit SN; Hundley HA
Wiley Interdiscip Rev RNA; 2016; 7(1):113-27. PubMed ID: 26612708
[TBL] [Abstract][Full Text] [Related]
38. ADAR RNA editing below the backbone.
Keegan L; Khan A; Vukic D; O'Connell M
RNA; 2017 Sep; 23(9):1317-1328. PubMed ID: 28559490
[TBL] [Abstract][Full Text] [Related]
39. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript.
Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA
RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568
[TBL] [Abstract][Full Text] [Related]
40. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.
Lehmann KA; Bass BL
Biochemistry; 2000 Oct; 39(42):12875-84. PubMed ID: 11041852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
